Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
hVSMC |
Human primary vascular smooth muscle cells | Human | vasculature | primary cell | adherent | plasmid | stable transfection | Metafectene | publication | G. Weisinger et al., Exp. Cell Res., 2013, 319: 1586-1593, doi.org/10.1016/j.yexcr.2013.04.001 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | oligonucleotide | Metafectene | publication | A. H. Wagner et al., Arterioscler Thromb Vasc Biol, Nov 2009; 29: 1894 - 1901 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | J. Yang et al., Oncology Reports, 2015, 34: 2745-2751; DOI: 10.3892/or.2015.4223 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Thakker et al., Oncotarget, 2018, 9 (1): 1210-1228 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Cardiovasc Res, Jan 2013; 97: 143 - 152 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Am J Physiol Heart Circ Physiol, Jan 2012; 302: H135 - H142 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S. Bellou et al., Am J Physiol Cell Physiol, Dec 2009; 297: C1477 - C1489 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | oligonucleotide | Metafectene | application note | ![]() |
|||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050-2057, doi.org/10.1016/j.bbrc.2017.08.023 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | N. Kostopoulou et al., J. Cell Sci., 2021, 134, jcs246892, doi:10.1242/jcs.246892 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050e2057 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Korean Circ. J., 2012, 42: 239-245, doi.org/10.4070/kcj.2012.42.4.239 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S. Zografou et al., J. Cell Sci., Oct 2012; 125: 4780 - 4790 | Link | ||
HuP-T3 |
Human pancreatic adenocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | J. Pahle, Dissertation, 2017, Humboldt-Universität zu Berlin | Link | |||
HuH7.5 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | N. Hagen, Dissertation, 2013, Universität Hamburg | Link | ||
HuH7.5 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene EASY | publication | S. Malmström, Dissertation, 2012, University of Gothenburg | Link | |||
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | miRNA | Metafectene PRO | publication | J. Tian, Phd thesis, 2021, Murdoch University | Link | |||
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | miRNA | cotransfection (plasmid/miRNA) | Metafectene PRO | publication | J. Tian, Thesis, 2015, Murdoch University | Link | ||
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | miRNA | cotransfection (plasmid/miRNA) | Metafectene PRO | publication | W. Lui, Honours Thesis, Murdoch University, Perth | Link | ||
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Magnetofection | Metafectene PRO | publication | A. M. Sauer et al., J Control Release, Jul 2009; 137(2): 136-45 | |||
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | J. W. Tay et al., J. of Thrombosis and Haemostasis, 2013, 11: 1547–1555, DOI: 10.1111/jth.12331 | Link | ||
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/miRNA) | Metafectene PRO | publication | W. Lui, Honours Thesis, Murdoch University, Perth | Link |